Cite
HARVARD Citation
Peron, J. et al. (n.d.). 2380 A new method to assess and test statistically the chance of a better outcome based on several endpoints in randomized trials, the case of erlotinib in metastatic pancreatic cancer. European journal of cancer. pp. S463-. [Online].